ControlRad, Inc., technology will now be available on Siemens’ interventional imaging systems.
ControlRad, Inc., announced this week it has secured U.S. Food & Drug Administrationg 510(k) clearance for its ControlRad Select system designed to reduce unnecessary radiation exposure during fluoroscopically guided procedures.
This technology, which uses proprietary semi-transparent filters, a user-interface tablet, and image processing algorithms, retrofitted onto existint Siemens Artis zee interventional imaging systems, can reduce radiation dose by 85 percent for images captured in cath, interventional radiology, and electrophysiology labs, said ControlRad CEO Guillaume Bailliard.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-newsletter here.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Female Representation in Radiology: Where Things Stand
March 25th 2024Women comprise nearly 80 percent of breast imaging departments and 45 percent of pediatric radiology departments at academic institutions, but burnout, the COVID-19 pandemic and discrimination have impeded further progress in radiology, according to a recently published literature review.